Associations between insulin pump self-management and HbA1c in type 1 diabetes
- PMID: 36786049
- DOI: 10.1111/dme.15068
Associations between insulin pump self-management and HbA1c in type 1 diabetes
Abstract
Aims: Insulin pump self-management is important for glycaemic outcomes. We aimed to investigate associations between self-management factors and HbA1c.
Methods: Adult insulin pump users with type 1 diabetes (n = 770) completed an online questionnaire. The latest HbA1c and demographics were extracted from national registries. Associations between HbA1c and self-management (use of advanced features, timing of infusion set change, timing of meal bolus, data-upload and pump settings adjustments) were investigated using backward selected linear regression models.
Results: Of the 699 responders eligible for this study, 60% were women; the median age and diabetes duration were 49 and 25 years, respectively. Significant associations with HbA1c were found for changing infusion set every 0-4 days relative to 5-10 days (-5 mmol/mol (-0.4%), p = 0.003), and for never/rarely missing a bolus (-6 mmol/mol (-0.5%), p < 0.001) relative to often missing a bolus. Timing insulin 10-15 min before meal relative to after meal start was also associated with lower HbA1c (-3 mmol/mol (-0.3%), p = 0.023). Self-adjusting pump settings showed the strongest association with lower HbA1c (-6 mmol/mol (-0.6%), p < 0.001) relative to health care professionals doing all adjustments.
Conclusion: Self-adjusting insulin pump settings, optimal timing and few omissions of meal boluses, and timely change of infusion set are associated with lower HbA1c.
Trial registration: ClinicalTrials.gov NCT04311164.
Keywords: HbA1c; diabetes education; empowerment; insulin pump; self-management; type 1 diabetes.
© 2023 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.
References
REFERENCES
-
- Foster NC, Beck RW, Miller KM, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018. Diabetes Technol Ther. 2019;21(2):66-72. doi:10.1089/dia.2018.0384
-
- Gajewska KA, Bennett K, Biesma R, Sreenan S. Low uptake of continuous subcutaneous insulin infusion therapy in people with type 1 diabetes in Ireland: a retrospective cross-sectional study. BMC Endocr Disord. 2020;20(1):92. doi:10.1186/s12902-020-00573-w
-
- The Swedish National Diabetes Register (NDR). Accessed August 2022. https://www.ndr.nu/#/knappen
-
- Barnard KD, Breton MD. Diabetes technological revolution: winners and losers? J Diabetes Sci Technol. 2018;12(6):1227-1230. doi:10.1177/1932296818788872
-
- Tanenbaum ML, Hanes SJ, Miller KM, Naranjo D, Bensen R, Hood KK. Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential intervention targets. Diabetes Care. 2017;40(2):181-187. doi:10.2337/dc16-1536
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical